Great Point Partners LLC

SEC CIK: 0001281446
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Great Point Partners LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overview All 13F holders of VRTX Full Q2 2026 holdings

Shares (Q2 2022): 0; Sold out in Q2 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q3 2021

Holdings of VRTX by Great Point Partners LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2022	0	$0	0.0%	−85,000−100.0%	Sold out	Holders
Q1 2022	85,000	$22.2M	5.4%	00.0%	Unchanged	Holders
Q4 2021	85,000	$18.7M	4.2%	00.0%	Unchanged	Holders
Q3 2021	85,000	$15.4M	3.6%	+85,000	New	Holders